Full Coverage

FDA Warns Sanofi-Aventis Over Misleading Material

                   
pharmalot.com
Oct 28, 2009
 
Story Timeline:  26 days

The agency sent a warning letter to the drug maker for distributing “misleading” promotional material for its Uroxatral medication for urinary problems caused by an enlarged prostate. The problem was a promotional card touting... [read full story]                    

powered by
Add Comment
Latest article on this story:

UPDATE 2-Sanofi gets FDA warning over Uroxatral promotion

 finanznachrichten.de Oct 27, 2009
First article on this story:

UPDATE 2-Sanofi gets FDA warning over Uroxatral promotion

 finanznachrichten.de Oct 27, 2009
Selected publications with coverage of this story:
pharmalot.com finanznachrichten.de
RELATED
Found 1 documents:
                   

UPDATE 2-Sanofi gets FDA warning over Uroxatral promotion

finanznachrichten.de
Oct 27, 2009
 

NEW YORK, Oct 27 (Reuters) - The U.S. Food and Drug Administration has sent a warning letter to Sanofi-Aventis accusing the French drugmaker of distributing misleading promotional material on its Uroxatral treatment for urinary...

powered by